|Net Assets||6.59 Bil|
- Last NAV update 5/23/2013 4:00 PM ET
|The investment seeks long-term growth of capital. The fund focuses principally on common stocks that it believes are undervalued at the time of purchase and have the potential for growth. While the fund normally invests in U.S. companies, it also may invest in foreign securities. The fund may invest in securities of issuers with any market capitalization. It is non-diversified.|
- Year to date performance as of 5/22/2013 8:00 PM ET
|Fund Manager||Robert Goldfarb|
|Minimum Initial Purchase||5,000.00|
|Minimum IRA Investment||2,500.00|
- * Annualized returns
- Performance as of 5/22/2013 8:00 PM ET
|Net Assets||6.59 Bil||851.31 Mil|
|Avg Market Cap||21.78 Bil||42.44 Bil|
|NAME||% NET ASSETS|
|Valeant Pharmaceuticals International Inc||11.59%|
|Berkshire Hathaway Inc Class A||7.32%|
|Mohawk Industries, Inc.||4.02%|
|Berkshire Hathaway Inc Class B||3.55%|
|Advance Auto Parts Inc||3.10%|
|Precision Castparts Corp.||3.07%|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.